<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01837394</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2011-029</org_study_id>
    <nct_id>NCT01837394</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy</brief_title>
  <official_title>Ultrasound-guided Block of the Saphenous Nerve and Obturator Nerve, Posterior Branch, for Postoperative Pain Management After Ambulatory Knee Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jens Borglum Neimann</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we wish to investigate the effect of ultrasound (US) -guided block of the
      saphenous nerve (SN) and the posterior branch of the obturator nerve (ONP) on postoperative
      pain and the use of opioids (morphine-like pain medicine) in the first 24 hours following
      ambulatory knee arthroscopy.

      We wish to investigate the analgesic effect of these two blocks compared to placebo
      (injection of local anesthetic with known pain blocking properties compared with injection of
      a saline solution), when used as a supplement to conventional oral analgesics.

      We hypothesize that patients receiving the active treatment may experience less pain during
      the first 24 hours after their operation than patients receiving the placebo treatment, and
      possibly require less opioid analgesics, experience less opioid related side effects and have
      a higher function level in this period than patients receiving the placebo treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain on knee flexion</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>VRS (Verbal Rating Scale) score 0-10 on active flexion of the knee to 45 degrees, measured at 0, ½, 1, 2, 3, 4, 6, 8, 12 and 24 hours postoperatively and analyzed by area under curve (AUC) analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at rest</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>VRS (verbal rating score) 0-10 at rest, measured at 0, ½, 1, 2, 3, 4, 6, 8, 12 and 24 hours postoperatively and analyzed by area under curve (AUC) analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to opioid intake</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>First time the patient needs to take supplementary opioids in the postoperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioid intake</measure>
    <time_frame>24 hours</time_frame>
    <description>Total dose of opioids taken in the first 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>VRS score 0-10, measured at 0, ½, 1, 2, 3, 4, 6, 8, 12 and 24 hours postoperatively and analyzed by area under curve (AUC) analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of times the patient has vomited in the first 24 hours postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of antiemetics</measure>
    <time_frame>24 hours</time_frame>
    <description>Total dose of antiemetics taken during the first 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PACU length of stay</measure>
    <time_frame>24 hours</time_frame>
    <description>Total length of stay in the post anesthetic care unit (PACU) after the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function level: Barthel Index/100</measure>
    <time_frame>24 hours</time_frame>
    <description>Modified Barthel Index/100 score 24 hours after the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function level: Short form (SF) -8</measure>
    <time_frame>24 hours</time_frame>
    <description>Short form (SF) -8 questionnaire 24 hours postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Nausea and Vomiting</condition>
  <condition>Postoperative Function Level</condition>
  <arm_group>
    <arm_group_label>Block arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided block of the SN and ONP with 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ultrasound guided placebo block of the SN and ONP with 7.5 ml of isotonic saline solution injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Block of the SN and ONP</intervention_name>
    <description>7.5 ml of Ropivacaine 7.5 mg/ml injected at each site</description>
    <arm_group_label>Block arm</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo block</intervention_name>
    <description>7.5 ml of isotonic saline solution 154 mmol/l injected at each site</description>
    <arm_group_label>Placebo arm</arm_group_label>
    <other_name>NaCl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <arm_group_label>Block arm</arm_group_label>
    <arm_group_label>Placebo arm</arm_group_label>
    <other_name>Acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>5 mg as needed</description>
    <arm_group_label>Block arm</arm_group_label>
    <arm_group_label>Placebo arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron</intervention_name>
    <description>4 mg i.v. as needed in the PACU</description>
    <arm_group_label>Block arm</arm_group_label>
    <arm_group_label>Placebo arm</arm_group_label>
    <other_name>Zofran</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metoclopramide</intervention_name>
    <description>10 mg tablet as needed in the postoperative period after discharge from the PACU</description>
    <arm_group_label>Block arm</arm_group_label>
    <arm_group_label>Placebo arm</arm_group_label>
    <other_name>Emperal</other_name>
    <other_name>Primperan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned ambulatory knee arthroscopy, except cruciate ligament surgery

          -  American Society of Anesthesiologists (ASA) class 1-3

        Exclusion Criteria:

          -  Cannot cooperate

          -  Do not speak or understand Danish

          -  Daily use of opioid analgesics

          -  Allergy towards any of the drugs used in the investigation

          -  Medicine abuse (at the investigators discretion)

          -  Alcohol abuse, as defined by the National Board of Health

          -  General anesthesia contraindicated, or the patient wants spinal anesthesia

          -  Visualization of necessary structures by ultrasound not possible, or block not
             possible for other technical reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bo Westergaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2013</study_first_submitted>
  <study_first_submitted_qc>April 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2013</study_first_posted>
  <last_update_submitted>November 5, 2013</last_update_submitted>
  <last_update_submitted_qc>November 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Jens Borglum Neimann</investigator_full_name>
    <investigator_title>MD, PhD, MBA</investigator_title>
  </responsible_party>
  <keyword>Nerve block</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>Saphenous nerve</keyword>
  <keyword>Obturator nerve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Metoclopramide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

